Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
9,242
+622
+7% +$72.8K 0.05% 99
2026
Q1
$1.04M Sell
8,620
-125
-1% -$14.4K 0.06% 98
2025
Q4
$920K Sell
8,745
-745
-8% -$69.9K 0.05% 101
2025
Q3
$796K Sell
9,490
-87
-0.9% -$7.17K 0.05% 114
2025
Q2
$758K Sell
9,577
-143
-1% -$11.4K 0.05% 114
2025
Q1
$872K Sell
9,720
-501
-5% -$46.8K 0.07% 93
2024
Q4
$1.02M Buy
10,221
+448
+5% +$46.2K 0.08% 81
2024
Q3
$1.11M Sell
9,773
-32
-0.3% -$3.8K 0.09% 78
2024
Q2
$1.21M Buy
9,805
+461
+5% +$59.4K 0.11% 70
2024
Q1
$1.23M Buy
9,344
+36
+0.4% +$4.44K 0.12% 70
2023
Q4
$1.01M Buy
9,308
+788
+9% +$81.8K 0.11% 77
2023
Q3
$877K Buy
8,520
+164
+2% +$17.7K 0.11% 77
2023
Q2
$964K Sell
8,356
-8
-0.1% -$908 0.12% 72
2023
Q1
$890K Sell
8,364
-831
-9% -$89.7K 0.12% 75
2022
Q4
$1.02M Buy
9,195
+74
+0.8% +$7.56K 0.14% 62
2022
Q3
$785K Buy
9,121
+132
+1% +$11.8K 0.13% 68
2022
Q2
$819K Buy
8,989
+922
+11% +$81.7K 0.13% 71
2022
Q1
$662K Buy
8,067
+401
+5% +$31.6K 0.1% 86
2021
Q4
$587K Sell
7,666
-741
-9% -$59K 0.09% 89
2021
Q3
$631K Buy
8,407
+741
+10% +$56.4K 0.1% 95
2021
Q2
$596K Sell
7,666
-217
-3% -$16.1K 0.1% 102
2021
Q1
$580K Buy
7,883
+238
+3% +$17.6K 0.25% 87
2020
Q4
$597K Sell
7,645
-5,386
-41% -$412K 0.27% 81
2020
Q3
$1.03M Sell
13,031
-491
-4% -$38.5K 0.41% 55
2020
Q2
$998K Buy
13,522
+417
+3% +$31.4K 0.43% 53
2020
Q1
$962K Sell
13,105
-2,256
-15% -$177K 0.47% 47
2019
Q4
$1.33M Buy
15,361
+780
+5% +$64.1K 0.52% 46
2019
Q3
$1.17M Sell
14,581
-2,742
-16% -$220K 0.52% 47
2019
Q2
$1.39M Buy
17,323
+452
+3% +$34.6K 0.62% 40
2019
Q1
$1.34M Sell
16,871
-1,011
-6% -$75.6K 0.59% 44
2018
Q4
$1.3M Buy
17,882
+82
+0.5% +$5.79K 0.63% 45
2018
Q3
$1.21M Sell
17,800
-443
-2% -$28.2K 0.5% 50
2018
Q2
$1.06M Sell
18,243
-597
-3% -$33.7K 0.47% 52
2018
Q1
$979K Sell
18,840
-1,436
-7% -$77.6K 0.45% 54
2017
Q4
$1.09M Buy
20,276
+947
+5% +$52.5K 0.48% 51
2017
Q3
$1.18M Sell
19,329
-488
-2% -$29.6K 0.58% 42
2017
Q2
$1.21M Sell
19,817
-178
-0.9% -$10.8K 0.62% 41
2017
Q1
$1.21M Buy
19,995
+286
+1% +$17.4K 0.63% 40
2016
Q4
$1.11M Buy
19,709
+286
+1% +$16.7K 0.58% 42
2016
Q3
$1.16M Buy
19,423
+91
+0.5% +$5.32K 0.63% 42
2016
Q2
$1.06M Sell
19,332
-127
-0.7% -$6.76K 0.59% 44
2016
Q1
$982K Sell
19,459
-2,299
-11% -$113K 0.54% 49
2015
Q4
$1.1M Sell
21,758
-851
-4% -$42.9K 0.61% 40
2015
Q3
$1.06M Buy
22,609
+1,308
+6% +$69.5K 0.64% 41
2015
Q2
$1.16M Buy
21,301
+173
+0.8% +$9.7K 0.66% 38
2015
Q1
$1.16M Buy
21,128
+1,349
+7% +$76.4K 0.73% 35
2014
Q4
$1.07M Sell
19,779
-161
-0.8% -$8.97K 0.66% 38
2014
Q3
$1.13M Buy
19,940
+201
+1% +$11.3K 0.71% 36
2014
Q2
$1.09M Buy
19,739
+29
+0.1% +$1.58K 0.66% 38
2014
Q1
$1.07M Buy
+19,710
New +$1.02M 0.7% 35

Other funds holding MRK

TCI Wealth Advisors's MRK Position: Q2 2026 in Review

TCI Wealth Advisors increased its Merck (MRK) stake by 7.2% in Q2 2026, buying an estimated $72.8K and bringing the position to 9,242 shares worth $1.19M. The position accounts for 0.05% of the portfolio, ranked #99.

TCI Wealth Advisors first reported a position in MRK in Q1 2014 and has held it in 50 quarters since. The position peaked at $1.39M in Q2 2019. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TCI Wealth Advisors held 9,242 shares of Merck worth $1.19M as of Q2 2026.
  • TCI Wealth Advisors bought 622 Merck shares in Q2 2026, an estimated $72.8K.
  • Merck made up 0.05% of TCI Wealth Advisors's portfolio in Q2 2026, its #99 holding.
  • TCI Wealth Advisors first reported a position in Merck in Q1 2014 and has held it in 50 quarters since.
  • TCI Wealth Advisors's Merck position peaked at $1.39M in Q2 2019.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.